NovaBay reports $3.6 million quarterly net loss

NovaBay Pharmaceuticals reported a net loss of $3.6 million for the first quarter of 2014, compared with a loss of $4 million for the same period in 2013, according to a press release.Cash, cash equivalents and short-term investments increased to $15.2 million, compared with $13.1 million in the second quarter 2013. License and collaboration revenue was $300,000, down from $1 million in the first quarter 2013.